JAJ International Revenue and Competitors
Estimated Revenue & Valuation
- JAJ International's estimated annual revenue is currently $7.8M per year.
- JAJ International's estimated revenue per employee is $155,000
Employee Data
- JAJ International has 50 Employees.
- JAJ International grew their employee count by 9% last year.
JAJ International's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
JAJ International Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is JAJ International?
JAJ International, Inc is a worldwide leading company in the rapid one-step diagnostic industry. Founded in 1998, our scientists have developed extraordinary lines of products, many of which hold unique patents. JAJ International develops, manufactures, and markets a wide array of one-step diagnostic test kit, including Cardio markers, Infectious diseases, Drug abuse, Sexually transmitted diseases, Pregnancy and Fertility etc. Pioneered in technological breakthroughs, JAJ is the first, and in many cases the only, company who can achieve rapid tests of equal or better quality than the equivalence in Elisa tests. After many years of Research and Development and many technological breakthroughs, JAJ International is poised to take a leadership position in the Rapid Diagnostic Market.
keywords:N/AN/A
Total Funding
50
Number of Employees
$7.8M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.4M | 50 | -7% | N/A |
#2 | $4.8M | 50 | 9% | N/A |
#3 | $8.8M | 50 | 11% | N/A |
#4 | $8.2M | 50 | N/A | N/A |
#5 | $5.3M | 50 | 9% | $3M |